anticoagulation | Page 5 of 6

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 28 November, 2025 0

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 27 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 26 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: anticoagulation

Polymer-Free DES Also Show Efficacy in Anticoagulated Patients with High Risk...

RE-DUAL PCI: Anti-Thrombotic Management in Patients with Atrial Fibrillation and PCI

SOLACI CACI 2017 | Prevention of valvular thrombosis: antiaggregation or anticoagulation?

Incidence, characteristics, and treatment of valve thrombosis after TAVR

Catheter-directed thrombolysis for pulmonary embolism: a safe technique

Closing off the Appendage While Performing Cardiac Surgery Results in a...

Apixaban: An Alternative for Patients with Atrial Fibrillation Undergoing TAVR?

Anticoagulated Patients with Atrial Fibrillation Undergoing Angioplasty: How to Treat Them

Andexanet Alfa: a Good Antidote against Anti Xa Agents

Anticoagulation and PCI: How Long Should Triple Therapy Last?

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos